Otsuka’s Battle To Block Abilify Generics Heats Up As Patent Expires
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA says it may ultimately agree with Otsuka on question of orphan exclusivity’s power over carve-outs, but agency still objects to request for preliminary injunction.